Right Turn Show - Decoding the Use of Dapagliflozin and its Combinations with Metformin and Sitagliptin in Specialty Care Settings
Written By : Dr J.C. Mohan
Written By : Prof. Abdul Hamid Zargar
Published On 2024-12-18 06:30 GMT | Update On 2024-12-18 09:13 GMT
Advertisement
Presenting Episode 2 of the Right Turn Show, in this episode, insights from leading experts are explored on the practical application of dapagliflozin and its combinations in speciality settings. The previous episode focused on the consideration of dapagliflozin in specialty care settings. Building on that, this episode delves into the various Fixed Dose Combinations (FDCs) of dapagliflozin.
Dapagliflozin remains a preferred therapy among clinicians for managing Type 2 Diabetes Mellitus (T2DM), while also offering significant benefits in the treatment of heart failure and chronic kidney disease (CKD).
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.